Table 1. Preoperative characteristics of the patients (by groups).
| Parameter | Study Group (n=39) Me (Q25; Q75) | Control Group (n=45) Me (Q25; Q75) | p-level | |
|---|---|---|---|---|
| Age, years | 60.1±4.71 | 60.3±6.51 | 0.851 | |
| Prostate volume (Ultrasound), mL | 31 (20.9; 36.3) | 34 (22; 48) | 0.202 | |
| Total PSA, ng/mL | 7.5 (5.3; 11.2) | 9.4 (6.1; 15.0) | 0.117 | |
| Division of patients based on Gleason sum, pts. (%) | ||||
| 2-4 | 3 (7.7) | 7 (15.6) | 0.353 | |
| 5-7 | 32 (82.1) | 36 (80.0) | ||
| 8-10 | 4 (10.2) | 2 (4.4) | ||
| Division of patients based on clinical stage, pts. (%) | ||||
| cT1c | 22 (56.4) | 21 (46.7) | 0.682 | |
| cT2a | 2 (5.1) | 3 (6.7) | ||
| cT2b | 5 (12.8) | 3 (6.7) | ||
| cT2c | 5 (12.8) | 7 (15.6) | ||
| cT3a | 3 (7.7) | 8 (17.8) | ||
| cT3b | 2 (5.1) | 3 (6.7) | ||
1
Mean ± Standard deviation